SCHEMBL2407291

SCHEMBL2407291

NC(=O)c1ccc(-n2cnc3cnc(N4CCCC4)nc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 1/20 0.46
▸ FGFR1 P11362 1/20 0.41
▸ HPGD P15428 4/20 0.40
▸ DYRK1A Q13627 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ USP2 O75604 2/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ CASP7 P55210 1/20 0.38
▸ JAK3 P52333 2/20 0.38
▸ RPS6KA3 P51812 1/20 0.37
▸ CHEK1 O14757 1/20 0.37
▸ PTPN11 Q06124 1/20 0.37
▸ MAPT P10636 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2410911 0.99 CFTR (0.45) CFTRFGFR1HPGDDYRK1AALDH1A1
SCHEMBL2405975 0.87 JAK3 (0.46) CFTRFGFR1ALDH1A1USP2CYP1A2
SCHEMBL2410186 0.85 MAPT (0.42) HPGDALDH1A1USP2CYP1A2HSD17B10
SCHEMBL2408774 0.84 HPGD (0.41) HPGDALDH1A1USP2CYP1A2HSD17B10
SCHEMBL2408379 0.84 RPS6KA3 (0.48) FGFR1HPGDALDH1A1USP2CYP1A2
SCHEMBL2408100 0.83 RPS6KA3 (0.47) FGFR1HPGDALDH1A1USP2CYP1A2
SCHEMBL17802582 0.80 CFTR (0.54) CFTRFGFR1HPGDDYRK1AALDH1A1
SCHEMBL2410246 0.79 CFTR (0.63) CFTRFGFR1HPGDDYRK1ARPS6KA3
SCHEMBL2408339 0.76 RPS6KA3 (0.48) HPGDALDH1A1USP2CYP1A2HSD17B10
SCHEMBL2408398 0.76 PTPN11 (0.41) ALDH1A1USP2CYP1A2HSD17B10CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011106168-A1 PURINE COMPOUNDS FOR TREATING AUTOIMMUNE AND DEMYELINATING DISEASES DCAM PHARMA INC (US) 2011-09-01 — — WO claimed
WO-2011106168-A1 PURINE COMPOUNDS FOR TREATING AUTOIMMUNE AND DEMYELINATING DISEASES DCAM PHARMA INC (US) 2011-09-01 — — WO disclosed
WO-2011106168-A1 PURINE COMPOUNDS FOR TREATING AUTOIMMUNE AND DEMYELINATING DISEASES DCAM PHARMA INC (US) 2011-09-01 — — WO disclosed
Send feedback